Analysis uncovers investment factors in Ukraine’s pharmaceutical sector, highlighting foreign interest and challenges.
The processes of globalization are often seen in the financial market, in particular in the form of the spread of foreign investment, which is an effective way for the development of national economies. In the modern world economy there is a problem of intensification of competition for investment resources by countries, economic entities of various industries and sectors of the economy. Priority strategic sectors of Ukraine's economy are underinvested, the volume of attracted foreign investments does not correspond to their economic and investment potential. Therefore, the urgent problem of economic science and practice is the formation of investment attractiveness of such industries to accelerate the attraction of foreign capital. Such a promising, high-tech, state- and socially significant industry for attracting foreign investment is the pharmaceutical industry of Ukraine, which became even more relevant during the COVID-19 pandemic. This article analyzes the approaches to defining the essence of international investment attractiveness and proposes the author's definition of this concept. The analysis of business environment of the pharmaceutical industry of Ukraine was conducted; its results are presented in this article. The collection and analysis of primary information was conducted by questioning experts. During this research, an authors’ approach of assessment of the investment attractiveness of pharmaceutical industry of Ukraine was presented and the approbation of it was conducted by authors. The factors of attractiveness of the pharmaceutical industry of Ukraine for foreign investors were determined. The factors limiting the investment attractiveness of the pharmaceutical industry of Ukraine were identified and practical recommendations on the directions of possible means to increase the attracted flows of foreign capital for the economic development of the industry are substantiated.
No takes yet. Share an insight, caveat, or question.
Starostina et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: